Health Dictionary Find a Doctor

Multiple myeloma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Hannan Javed, M.D.[2]; Haytham Allaham, M.D. [3]; Shyam Patel [4]

Overview

Overview

In 2012, the incidence of multiple myeloma was approximately 6.3 per 100,000 cases with a mortality rate of 3.3 per 100,000 cases in the United States. The prevalence of multiple myeloma was estimated to be 89,658 cases in 2012 in the United States. Multiple myeloma is the second most common blood cancer after non-Hodgkin’s lymphoma and 14th most common cancer overall in United States. Males are more commonly affected with multiple myeloma than females; the male to female ratio is approximately 1.54 to 1. Multiple myeloma usually affects individuals of the African American race. Asian individuals are less likely to develop multiple myeloma. The incidence of multiple myeloma increases with age.

Epidemiology and Demographics

Epidemiology and Demographics

Incidence

Multiple Myeloma Epidemiology
Estimated New Cases in 2018 30,770
% of All New Cancer Cases 1.8%
Estimated Deaths in 2018 12,770
% of All Cancer Deaths 2.1%
5 Years Survival Rate (2008-2014) 50.7%
Adopted from National Cancer Institute[2]

Prevalence

Age

  • The incidence of multiple myeloma increases with age, and the median age at diagnosis is 69 years.[2]
Percent of New Cases by Age Group
Age Percent of New cases
<20
20-34 0.5%
35-44 2.8%
45-54 10.9%
55-64 23.2%
65-74 29.8%
75-84 23.7%
>84 9.0%
Adopted from National Cancer Institute[2]

Gender

Race

  • Among African Americans, multiple myeloma is one of the top 10 leading causes of cancer deaths.[5]
  • The incidence of multiple myeloma in the African American population is more than the European American population.
  • African Americans have a 2-fold higher age-standardized incidence rate of multiple myeloma than Caucasians. The incidence of multiple myeloma in African Americans is 9.6 per 100,000 persons. The incidence of Caucasians is 4.1 per 100,000 persons.[1]
New Cases per 100,000 Persons by Race/Ethnicity & Sex
Race Female Male
All Races 5.3 8.4
White 4.7 7.9
Black 11.6 15.9
Asian/Pacific Islander 3.1 4.9
American Indian/Alaska Native 5.5 6.2
Hispanic 5.0 7.6
Non-Hispanic 5.4 8.5
Adopted from National Cancer Institute[2]
Gallery
Adopted from National Cancer Institute
Multiple myeloma summary.[5]
Percent of new cases by age group: multiple myeloma.[5]
Number of new cases per 100,000 persons by race/ethnicity & sex: multiple myeloma.[5]>
Percent of deaths per age group: multiple myeloma.[5]
Number of deaths per 100,000 persons by race/ethnicity & sex multiple myeloma.[5]
Multiple myeloma percent of total new cancer csases in the United states.[5]
Five year survival percentage.[5]
New cases, deaths, and 5-Year relative survival.[5]
References

References

  1. 1.0 1.1 1.2 Hong J, Lee JH (2016). “Recent advances in multiple myeloma: a Korean perspective”. Korean J Intern Med. 31 (5): 820–34. doi:10.3904/kjim.2015.408. PMC 5016289. PMID 27604794.
  2. 2.00 2.01 2.02 2.03 2.04 2.05 2.06 2.07 2.08 2.09 2.10 2.11 “Myeloma – Cancer Stat Facts”.
  3. Plasma cell neoplasm.National cancer institute (2015)http://www.cancer.gov/types/myeloma/hp/myeloma-treatment-pdq#cit/section_1.1 Accessed on September, 20th 2015
  4. 4.0 4.1 A snapshot of myeloma. National cancer institute(2014)http://www.cancer.gov/research/progress/snapshots/myeloma Accessed on September, 20th 2015
  5. 5.00 5.01 5.02 5.03 5.04 5.05 5.06 5.07 5.08 5.09 5.10 Seer stat fact sheet. National cancer institute (2015)http://seer.cancer.gov/statfacts/html/mulmy.html Accessed on September, 20th 2015
  6. “Myeloma – Cancer Stat Facts”.
  7. Jia R, Xue L, Liang H, Gao K, Li J, Zhang Z (2015). “Surgery combined with radiotherapy for the treatment of solitary plasmacytoma of the rib: a case report and review of the literature”. J Cardiothorac Surg. 10: 125. doi:10.1186/s13019-015-0335-5. PMC 4605096. PMID 26464186.
  8. Multiple myeloma. Radiopaedia (2015)http://radiopaedia.org/articles/multiple-myeloma-1 Accessed on September, 20th 2015

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH